BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
331 – 340 of 3081
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Towards improved oncological treatment of esophageal and gastric cancer. Clinical and translational studies.
- Thesis › Doctoral thesis (compilation)
-
Mark
Vi måste ta ställning till den nya gentekniken
(2019) In Svenska Dagbladet, Stockholm
- Contribution to specialist publication or newspaper › Newspaper article
-
Mark
Cytotoxicity of New Damsin Derivatives in Breast Cancer Cells
- Contribution to journal › Article
-
Mark
Selective Cytotoxicity of Damsin Derivatives in Breast Cancer Cells
- Contribution to journal › Article
-
Mark
Comparison between silicon photomultiplier-based and conventional PET/CT in patients with suspected lung cancer—a pilot study
- Contribution to journal › Article
-
Mark
Survival benefits from concomitant chemoradiotherapy before radical surgery in stage IVA sinonasal mucosal melanoma?
- Contribution to journal › Article
-
Mark
Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
(2019) In Journal of visualized experiments : JoVE
- Contribution to journal › Article
-
Mark
Depletion of the transcriptional coactivators CREB-binding protein or EP300 downregulates CD20 in diffuse large B-cell lymphoma cells and impairs the cytotoxic effects of anti-CD20 antibodies
- Contribution to journal › Article
-
Mark
Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe)
(2019) In Scandinavian Journal of Urology
- Contribution to journal › Article
